Endovascular treatment of recurring type A dissection after total aortic arch debranching.
Standard treatment method of the aortic arch pathologies is surgical replacement which requires cardiopulmonary bypass and deep hypothermic circulatory arrest. However, this approach is associated with major operative risks. Combination of debranching and thoracic endovascular aortic arch repair (TEVAR) has emerged as an alternative treatment modality in high-risk patients. This report describes successful staged hybrid treatment of a 50-year-old male patient with recurring type A dissection. It is concluded that staged debranching and TEVAR is a feasible option and provides aortic repair without increase of risk.